Alliance A031501: Phase III randomized adjuvant study of MK-3475 (pembrolizumab) in muscle-invasive and locally advanced urothelial carcinoma (MIBC) (AMBASSADOR) versus observation.

被引：12

作者：

Apolo, Andrea B.

Rosenberg, Jonathan E.

Kim, William Y.

Chen, Ronald C.

Sonpavde, Guru

Srinivas, Sandy

Mortazavi, Amir

Watt, Colleen

Mallek, Marissa

Graap, Katherine

Diaz, Carlos

Odegaard, Meagan

Ballman, Karla V.

Morris, Michael J.

机构：

[1] NCI, Genitourinary Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[4] Univ N Carolina, Chapel Hill, NC 27515 USA

[5] Dana Farber Canc Inst, Dept Genitourinary Oncol, Boston, MA 02115 USA

[6] Stanford Univ, Stanford, CA 94305 USA

[7] Ohio State Univ, Wexner Med Ctr, Arthur G James Canc Hosp, Columbus, OH 43210 USA

[8] Univ Chicago, Chicago, IL 60637 USA

[9] NCI, Bethesda, MD 20892 USA

[10] Mayo Clin, Rochester, MN USA

[11] Weill Cornell Med, New York, NY USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.7_suppl.TPS504

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS504

引用

页数：1